Current Use of Oral Anticoagulation Therapy in Elderly Patients with Atrial Fibrillation: Results from an Italian Multicenter Prospective Study—The ISNEP Study

Current Use of Oral Anticoagulation Therapy in Elderly Patients with Atrial Fibrillation: Results from an Italian Multicenter Prospective Study—The ISNEP Study

Background: Atrial fibrillation (AF) is the most common heart arrhythmia, and its prevalence increases with age. Oral Anticoagulant Therapy (OAT) with non-vitamin K antagonist oral anticoagulants (NOACs) or vitamin K antagonists (VKAs) is essential to avoid thromboembolic events in AF. However, this...

Full description

Bibliographic Details
Main Authors: Francesco De Stefano, Alberto Benassi, Alberto Maria Cappelletti, Francesco Donatelli, Damiano Regazzoli, Salvatore Tolaro, Francesca Perego, Angelo Silverio, Alessandra Scatteia, Pasquale Guarini, Santo Dellegrottaglie, Simona Mariani, Elpidio Pezzella, Gennaro Galasso, Francesco Caiazza, on behalf of ISNEP Investigators
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Journal of Personalized Medicine
Subjects:
atrial fibrillation
elderly
non-vitamin k antagonist oral anticoagulants
vitamin K antagonists
Online Access:https://www.mdpi.com/2075-4426/12/9/1419

Internet

https://www.mdpi.com/2075-4426/12/9/1419

Similar Items